Blogs
Why Sample Matrix Choice Matters Choosing the right sample matrix is one of the most critical decisions when designing a flow cytometry assay. Each option offers unique advantages and limitations that can directly impact data quality, logistics, and study outcomes. Flow cytometry requires intact, viable cells. The power of flow…
Podcasts
In episode #23 of The Conversational Flow, Adam and Brian tackle the question: When can flow cytometry be applied to non-blood matrices, and what must be considered? Using sputum analysis as a case study, they outline the challenges of clinical trial sample collection, emphasizing the importance of pre-analytical factors like…
Blogs
If you’ve worked in drug development, you already know that the road from discovery to clinical success is long, expensive, and rarely linear. One of the most pivotal checkpoints in that journey is cytotoxicity testing. Whether you’re developing a small molecule, a biologic, or a cell therapy like CAR‑T, the…
Podcasts
In this episode, the hosts introduce Karla Moncada, who shares her professional journey from Flowcore management to her current role at KCAS Bio, and unveils her new KCAS Bio video series, Karla’s Corner, aimed at fostering year-round conversations within the flow cytometry community. Karla emphasizes the value of personal connections…
September 22
- September 22
KCAS Bio will be attending the NCCG Annual Meeting 2025, taking place in San Francisco on September 22. This gathering, hosted by NorCal Cytometry Group, unites professionals across the scientific, regulatory, and biotech communities who are interested in the advancements in the field of flow cytometry. The annual meeting will…
October 23
- October 23
KCAS Bio will be attending MetroFlow 2025 Annual Meeting, taking place October 23 in New York, NY. The MetroFlow 2025 Annual Meeting brings together a dedicated community of flow cytometry professionals, including core facility directors, technical experts, researchers, and service providers. As such, this gathering provides a collaborative environment to…
September 26
- September 30
KCAS Bio will be attending the International Clinical Cytometry Society (ICCS) meeting 2025 on September 26-30 in Philadelphia, PA. This annual meeting brings together leaders and scientists to advance the understanding and application of technologies and methodologies in patient sample analysis. Through presentations and collaborative discussions, attendees will explore the…
Podcasts
In episode 21 of “The Conversational Flow” podcast, our hosts, Adam and Brian, explore the transformative power of gene therapy, starting things off by highlighting a compelling case involving CRISPR with milestones that once seemed impossible. They dive into the science behind CRISPR’s precise gene-editing capabilities and its potential for…
Posters & Papers
Discover in this poster presented by Dmitri Negorev at CYTO 2025 on the “Flow-cytometry based multiparametric profiling of neutrophil function”. Flow-cytometry Based Multiparametric Profiling of Neutrophil FunctionDownload If you have any questions about these services or any others offered by KCAS Bio,…
Podcasts
In this milestone 20th episode of “The Conversational Flow” podcast, hosts Adam and Brian dive into impactful developments across oncology, regulatory science, and bioanalytical innovation. The episode begins with a highlight of a recent major Keytruda study showing the first significant improvement in head and neck squamous cell carcinoma outcomes…
Blogs
In drug development, the journey from target identification to clinical candidate selection involves a series of critical steps, including compound screening, lead optimization, and pre-clinical testing. Each stage helps narrow the pool of potential therapeutics, with the goal of identifying the most promising candidates for clinical evaluation. Given the time,…
Blogs
At KCAS Bio, we offer expert flow cytometry services designed to support the evolving bioanalytical needs of immunology and biomarker projects for drug development. Whether you’re working in preclinical or clinical settings, our validated off-the-shelf panels save time, reduce risk, and deliver high-quality, reproducible data you can trust. Extensive Portfolio…